[Common name] Ceftazidime for Injection

[Ingredients] The major ingredient of the product is ceftazidime.

[Indication] It is indicated for such infections caused by sensitive gram-negative bacillus as the sepsis, lower respiratory tract infection, celiac and biliary tract infection, complexity, urinary tract infection and serious skin soft- tissue infection. In addition, it is particularly effective for such infections caused by multiple drug-resistant gram-negative bacilli as the infections inflicted on immunocompromised patients and nosocomial infection, as well as for central nervous system infections caused by gram-negative bacillus or pseudomonas aeruginosa.

[Specification] 1.0g

[Usage and Dosage] Intravenous injection or intravenous drip 1. For sepsis, lower respiratory tract infection and biliary tract infection, the dose shall be 4～6g a day, administered through intravenous drip or injection in 2～3 portions, a course of 10～14d. 2. For urinary tract infection and severe skin soft-tissue infection: the dose shall be 2～4g a day, administered through intravenous drip or injection in 2 portions, a course of 7～14d. 3. For some fatal infections, severe pseudomonas aeruginosa infection and central nervous system infections: the dose can be increased to 0.15～0.2g/kg a day, administered through intravenous drip or injection in 3 portions. 4. The usual dose for infants should be calculated on the basis of 30～100mg/kg a day, administered through intravenous drip in 2～3 portions.

[Package] Penicillin bottle packaging, 10 bottles per box.

[Expiry Date] 24 months

[Executive Standard] Chinese Pharmacopoeia, version 2010 (Vol. 2)

[Approval Document Number] G (J) H20033104